Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Saed Mirzadeh"'
Publikováno v:
ACS Omega, Vol 5, Iss 42, Pp 27016-27025 (2020)
Externí odkaz:
https://doaj.org/article/a4c35f3f8c8f4757b32c73371b3c8957
Autor:
Tara Mastren, Valery Radchenko, Allison Owens, Roy Copping, Rose Boll, Justin R. Griswold, Saed Mirzadeh, Lance E. Wyant, Mark Brugh, Jonathan W. Engle, Francois M. Nortier, Eva R. Birnbaum, Kevin D. John, Michael E. Fassbender
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-7 (2017)
Abstract A new method has been developed for the isolation of 223,224,225Ra, in high yield and purity, from a proton irradiated 232Th matrix. Herein we report an all-aqueous process using multiple solid-supported adsorption steps including a citrate
Externí odkaz:
https://doaj.org/article/c4ce5e09c2234701ae14e728aa214ee6
Autor:
Sandra M Davern, Timothy E McKnight, Robert F Standaert, Jennifer L Morrell-Falvey, Elena D Shpak, Udaya C Kalluri, Joanna Jelenska, Jean T Greenberg, Saed Mirzadeh
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0153621 (2016)
Effective methods for delivering bioprobes into the cells of intact plants are essential for investigating diverse biological processes. Increasing research on trees, such as Populus spp., for bioenergy applications is driving the need for techniques
Externí odkaz:
https://doaj.org/article/a6dddfff83974abd8e0687c6fb24f8c4
Autor:
Mark F McLaughlin, Jonathan Woodward, Rose A Boll, Jonathan S Wall, Adam J Rondinone, Stephen J Kennel, Saed Mirzadeh, J David Robertson
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e54531 (2013)
Targeted radiotherapies maximize cytotoxicty to cancer cells. In vivo α-generator targeted radiotherapies can deliver multiple α particles to a receptor site dramatically amplifying the radiation dose delivered to the target. The major challenge wi
Externí odkaz:
https://doaj.org/article/1a3a1583aa87460787fc214aaf7959c6
Autor:
Roy Copping, David A. Cullen, Saed Mirzadeh, Allison Peacock, Andrew Miskowiec, Miguel Toro-González, Sandra M. Davern
Publikováno v:
Journal of Nanotheranostics
Volume 2
Issue 1
Pages 3-50
Volume 2
Issue 1
Pages 3-50
The development of targeted alpha therapy (TAT) as a viable cancer treatment requires innovative solutions to challenges associated with radionuclide retention to enhance local tumor cytotoxicity and to minimize off-target effects. Nanoparticles (NPs
Autor:
Brian E. Zimmerman, Michael K. Schultz, Mengshi Li, Keith R Olewine, Daniel R. McAlister, Anthony J DeGraffenreid, Dongyoul Lee, Roy Copping, Stephen A. Graves, Edwin A Sagastume, Frances L. Johnson, Roy H Larsen, Saed Mirzadeh
Publikováno v:
Current Medicinal Chemistry. 27:7003-7031
Receptor-targeted image-guided Radionuclide Therapy (TRT) is increasingly recognized as a promising approach to cancer treatment. In particular, the potential for clinical translation of receptor-targeted alpha-particle therapy is receiving considera
Publikováno v:
Radiochimica Acta. 108:967-977
Unwanted targeting of healthy organs caused by the relocation of radionuclides from the target site has been one of the limiting factors in the widespread application of targeted alpha therapy in patient regimens. GdVO4 nanoparticles (NPs) were devel
Autor:
Miguel Toro-González, Larry J. Millet, Jessika V. Rojas, Jonathan Woodward, Ashley N. Dame, Sandra M. Davern, Carmen M. Foster, Saed Mirzadeh
Publikováno v:
Nanoscale. 12:9744-9755
Targeted alpha therapy (TAT) offers great promise for treating recalcitrant tumors and micrometastatic cancers. One drawback of TAT is the potential damage to normal tissues and organs due to the relocation of decay daughters from the treatment site.
Publikováno v:
Applied Radiation and Isotopes. 148:191-196
PubMed: 30978655
2-s2.0-85064014804
Tungsten-188 (t1/2 = 69.4 d) is routinely produced by double neutron capture using highly enriched 186W target, 186W(n,?)187W(n,?)188W reaction, at the ORNL 85 MWt High Flux Isotope Reactor. While the the
2-s2.0-85064014804
Tungsten-188 (t1/2 = 69.4 d) is routinely produced by double neutron capture using highly enriched 186W target, 186W(n,?)187W(n,?)188W reaction, at the ORNL 85 MWt High Flux Isotope Reactor. While the the